期刊文献+

芳香化酶抑制剂治疗乳腺癌的临床研究进展 被引量:2

Clinical advancement of aromatase inhibitors in the therapy for human breast cancer
下载PDF
导出
摘要 综述芳香化酶抑制剂治疗乳腺癌的作用机制。 We review the proceedings on the methods of how the aromatase inhibitor maintains its function, the recently developed drugs and the progress in the field of endocrine therapy for human breast cancer
出处 《中国癌症杂志》 CAS CSCD 2003年第1期69-71,共3页 China Oncology
关键词 乳腺癌 芳香化酶 芳香化酶抑制剂 breast cancer aromatase aromatase inhibitor
  • 相关文献

参考文献2

二级参考文献7

  • 1Kao Y C,Anticancer Res,1999年,19卷,3A期,2049页
  • 2Yue W,Cancer Res,1998年,58卷,5期,927页
  • 3Shozu M,Endocrinology,1998年,138卷,1610页
  • 4Sun X Z,J Steroid Biochem Mol Biol,1997年,63卷,1-3期,29页
  • 5Zhou D,J Steroid Biochem Mol Biol,1997年,61卷,3-6期,273页
  • 6Yue W,Cancer Res,1994年,54卷,19期,5092页
  • 7Winrich Rauschning,Kathleen I. Pritchard. Droloxifene, a new antiestrogen: Its role in metastatic breast cancer[J] 1994,Breast Cancer Research and Treatment(1):83~94

共引文献3

同被引文献15

  • 1韩晶,陆伟.长期服用三苯氧胺对绝经后乳腺癌患者子宫的影响[J].大连医科大学学报,2004,26(4):277-279. 被引量:3
  • 2佟晓珊,林晶,陈敏华,徐燕,许春梅,严昆,朱强,王彬.超声观察115例乳癌术后服用三苯氧胺及甲孕酮的子宫变化[J].中国超声医学杂志,1994,10(5):30-33. 被引量:2
  • 3吴绪峰,杨国梁.乳腺癌患者长期服用三苯氧胺与子宫内膜癌的关系[J].国外医学(肿瘤学分册),1996,23(2):110-111. 被引量:12
  • 4Fotiou S,Tserkezoglou A,H djieleftheriou G,et al. Tamifen associated utrine pathology in breast cancer patients with abnomal bleeding[J]. Anticance Res,1998,18(lB) :625 ~627.
  • 5Cohen I, Aotaras MM, Shapira J, et al. Postmenopausal tamoxifen treatment and endometrical pathology [ J ]. Obstet Gynecol Surv,1994,49(12) :823 ~ 825.
  • 6Killackey MA, Hakes TB, Pierce VK. Endometrial adenoearcinoma in breast cancer patients receiving antiestrogens[J].Cancer Treat Rep, 1985,69(2):237~238.
  • 7Vrecaj MU,Bebar S,Djurisic A,et al. Endometrial cancer after tamoxifen treatment of breast cancer. Results of a retrospective cohort study[J]. Eur J Gynaecol Oncol, 1999,20(1):20~25.
  • 8Kedar RP,Bourne TH,Powles TJ, et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevent trial[J]. Lancet, 1994,343: 1318~1321.
  • 9Sinawat S ,Chiyabutra T, Kleabkaew P. Surveillance for endometrial cancer in postmenopausal breast cancer patients taking tamoxifen [J]. Aisa Pac J Cancer Prev, 2003,4 (4): 327~330.
  • 10Morales L, Timmerman D, Neven P, et al. Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced ulterine changes in postmenopausal breast cancer patients[J]. Ann Oncol,2005,16(1):70~74.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部